Evaluation of a Modern System to Allow for Growth in Children With Scoliosis Versus a Conventional Treatment

Inclusion Criteria: * Age 5 - 10 years * Diagnosis of Early Onset Scoliosis with any of the following etiologies: Idiopathic Congenital Neuromuscular Syndromic Mesenchymal \- Significant growth potential defined by any of the following: pre peek growth velocity bone age \< 10; open triradiate cartilage * An expected significant spinal deformity of more than 80 degrees at skeletal maturity * Signed informed consent as legally required (patient, parents, etc.) * Willingness and ability of the patient to participate in the clinical investigation including imaging and FU procedures * Willingness and ability of the parents to support the patient in his/her study participation * Ability of the patient and parents to understand the content of the patient information / informed consent form and participate in the clinical investigation * Signed informed consent by patient / parent(s) Exclusion Criteria: * Curve magnitude and rigidity: Cobb greater than 100 degrees or bends less than 50 degrees * Prior spinal surgery * Skeletal maturity * Any not medically managed severe systemic disease * Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study